11![Effexorâ XR (venlafaxine hydrochloride) Extended-Release Capsules ] only This product’s label may have been revised after this insert was used Effexorâ XR (venlafaxine hydrochloride) Extended-Release Capsules ] only This product’s label may have been revised after this insert was used](https://www.pdfsearch.io/img/580e10e1c345572bcaac81a83f52756a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-06-08 09:31:21
|
---|
12![Effexor® (venlafaxine hydrochloride) Tablets Effexor® (venlafaxine hydrochloride) Tablets](https://www.pdfsearch.io/img/bc3dfdff6cb4f5d82aa3092f4d1d143c.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:50:52
|
---|
13![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Pristiq safely and effectively. See full prescribing information for Pristiq. • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Pristiq safely and effectively. See full prescribing information for Pristiq. •](https://www.pdfsearch.io/img/457c67b655fc402a5ed11e70b24e2c12.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:51:19
|
---|
14![Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:](https://www.pdfsearch.io/img/891a294a4be5cc546df9c9362a4a8e95.jpg) | Add to Reading ListSource URL: ahca.myflorida.comLanguage: English - Date: 2014-05-06 13:41:32
|
---|
15![Effexor XR® (venlafaxine hydrochloride) Extended-Release Capsules Rx only Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior Effexor XR® (venlafaxine hydrochloride) Extended-Release Capsules Rx only Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior](https://www.pdfsearch.io/img/a2782608be4b23d973f4e8f3ebbcade9.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-07-08 15:36:52
|
---|
16![Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:](https://www.pdfsearch.io/img/f7c61c3cc586ff842cc329806f518ada.jpg) | Add to Reading ListSource URL: www.ahca.myflorida.comLanguage: English - Date: 2014-05-06 13:41:32
|
---|
17![Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:](https://www.pdfsearch.io/img/5b0e5a8b86ad82aaba088eb017bb2b70.jpg) | Add to Reading ListSource URL: www.fdhc.state.fl.usLanguage: English - Date: 2014-05-06 13:41:32
|
---|
18![Oregon Health Authority Division of Medical Assistance Programs Monthly 7/11 Drug Carveout List NDC Code Label Name Desc Oregon Health Authority Division of Medical Assistance Programs Monthly 7/11 Drug Carveout List NDC Code Label Name Desc](https://www.pdfsearch.io/img/84c0f330d1ae53eda4814631e9c81f72.jpg) | Add to Reading ListSource URL: www.oregon.govLanguage: English - Date: 2013-10-09 15:30:35
|
---|
19![Organic chemistry / Medicine / Fluoxetine / Antidepressant / Paroxetine / Investigational New Drug / Food and Drug Administration / Desvenlafaxine / Escitalopram / Chemistry / Selective serotonin reuptake inhibitors / Organofluorides Organic chemistry / Medicine / Fluoxetine / Antidepressant / Paroxetine / Investigational New Drug / Food and Drug Administration / Desvenlafaxine / Escitalopram / Chemistry / Selective serotonin reuptake inhibitors / Organofluorides](/pdf-icon.png) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-01-13 09:43:10
|
---|
20![Pediatric Program Summary Statistics Since the pediatric exclusivity program began, 283 Written Requests have been issued and 88 drugs have been granted exclusivity. Among these, only fluoxetine has been approved for the Pediatric Program Summary Statistics Since the pediatric exclusivity program began, 283 Written Requests have been issued and 88 drugs have been granted exclusivity. Among these, only fluoxetine has been approved for the](https://www.pdfsearch.io/img/95d42b8434f932c8646697f422a8a2ac.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-01-13 09:43:14
|
---|